Yokoyama Y - Search Results

1

Multicenter Clinicopathological Study of High-Grade Serous Carcinoma Presenting as Primary Peritoneal Carcinoma.

Komiyama S, Nishijima Y, Kondo H, Nomura H, Yamaguchi S, Futagami M, Arai H, Yokoyama Y, Suzuki N, Mikami M, Kubushiro K, Aoki D, Udagawa Y, Nishimura R. Komiyama S, et al. Among authors: yokoyama y. Int J Gynecol Cancer. 2018 May;28(4):657-665. doi: 10.1097/IGC.0000000000001167. Int J Gynecol Cancer. 2018. PMID: 29324533

2

Significance of multi-drug-resistant proteins in predicting chemotherapy response and prognosis in epithelial ovarian cancer.

Yokoyama Y, Sato S, Fukushi Y, Sakamoto T, Futagami M, Saito Y. Yokoyama Y, et al. J Obstet Gynaecol Res. 1999 Dec;25(6):387-94. doi: 10.1111/j.1447-0756.1999.tb01182.x. J Obstet Gynaecol Res. 1999. PMID: 10680335

3

Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma.

Yokoyama Y, Sato S, Futagami M, Fukushi Y, Sakamoto T, Umemoto M, Saito Y. Yokoyama Y, et al. Gynecol Oncol. 2000 Jun;77(3):413-8. doi: 10.1006/gyno.2000.5802. Gynecol Oncol. 2000. PMID: 10831352

4

Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography.

Sato S, Yokoyama Y, Sakamoto T, Futagami M, Saito Y. Sato S, et al. Among authors: yokoyama y. Cancer. 2000 Aug 1;89(3):582-8. doi: 10.1002/1097-0142(20000801)89:3<582::aid-cncr13>3.0.co;2-#. Cancer. 2000. PMID: 10931457

5

Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours.

Sakamoto A, Yokoyama Y, Umemoto M, Futagami M, Sakamoto T, Bing X, Mizunuma H. Sakamoto A, et al. Among authors: yokoyama y. Br J Cancer. 2004 Aug 16;91(4):633-8. doi: 10.1038/sj.bjc.6602009. Br J Cancer. 2004. PMID: 15266333 Free PMC article.

6

Pharmacokinetic analysis of paclitaxel and carboplatin in a patient with advanced ovarian cancer during hemodialysis--case report.

Yokoyama Y, Futagami M, Higuchi T, Mizunuma H. Yokoyama Y, et al. Eur J Gynaecol Oncol. 2006;27(4):437-9. Eur J Gynaecol Oncol. 2006. PMID: 17009648

7

Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.

Xin B, Yokoyama Y, Shigeto T, Futagami M, Mizunuma H. Xin B, et al. Among authors: yokoyama y. Cancer. 2007 Aug 15;110(4):791-800. doi: 10.1002/cncr.22854. Cancer. 2007. PMID: 17582802 Free article.

8

A case of recurrent yolk sac tumor as spindle cell sarcoma of the abdominal wall.

Futagami M, Yokoyama Y, Shigeto T, Mizunuma H. Futagami M, et al. Among authors: yokoyama y. Eur J Gynaecol Oncol. 2010;31(6):690-3. Eur J Gynaecol Oncol. 2010. PMID: 21319519

9

Presentation of a patient with pT2bN1M0 small cell carcinoma of the uterine cervix who obtained long-term survival with maintenance chemotherapy, and literature-based discussion.

Futagami M, Yokoyama Y, Mizunuma H. Futagami M, et al. Among authors: yokoyama y. Eur J Gynaecol Oncol. 2011;32(1):99-102. Eur J Gynaecol Oncol. 2011. PMID: 21446337

10

[Successful optimal debulking surgery following chemotherapy combined with irinotecan hydrochloride and cisplatin for advanced clear cell carcinoma of the ovary].

Hirakawa H, Futagami M, Yokoyama Y, Hakamada K, Mizunuma H. Hirakawa H, et al. Among authors: yokoyama y. Gan To Kagaku Ryoho. 2011 May;38(5):857-60. Gan To Kagaku Ryoho. 2011. PMID: 21566454 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,720 results

Search Page

Filters